Full Press Release Details
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
BEAT Positive Sentiment
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Key Takeaway: HeartBeam has received a new U.S. patent that enhances the capabilities of its cable-free ECG device. This patent focuses on expanding the acoustic sensing and fluid monitoring features, indicating a significant advancement in their technology. The development could improve patient monitoring and diagnostics in cardiac care.
Price reaction · baseline $0.5779 (2026-07-13 close) · hit pre-market · clean, no other BEAT news in the window
day 0 close · peak
-3%
Market Sentiment Analysis
POSITIVE FACTORS
- HeartBeam has been awarded a new U.S. patent.
- The patent expands the capabilities of their ECG device.
- Innovative technology in acoustic sensing and fluid monitoring.
Frequently Asked Questions
What new capabilities does the HeartBeam patent provide?
The new patent expands the acoustic sensing and fluid monitoring capabilities of HeartBeam's ECG device.
Where is HeartBeam located?
HeartBeam is based in Santa Clara, California.
What type of device is HeartBeam's new patent related to?
The patent is related to a cable-free ECG device.